References
1. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med . 2004;350:1013–1022.
2. Schwartz PJ, Woosley RL. Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes. J Am Coll Cardiol . 2016;67:1639–1650.
3. Heist E. Kevin, Ruskin Jeremy N. Drug-Induced Arrhythmia.Circulation . 2010;122:1426–1435.
4. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med . 2020;382:727–733.
5. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.JAMA [Internet]. 2020 [cited 2020 Apr 21];Available from: https://jamanetwork.com/journals/jama/fullarticle/2764727
6. Roden Dan M., Harrington Robert A., Poppas Athena, Russo Andrea M. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment. Circulation [Internet]. [cited 2020 Apr 17];0. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047521
7. Sacher F, Fauchier L, Boveda S, de Chillou C, Defaye P, Deharo JC, Gandjbakhch E, Probst V, Cohen A, Leclercq C, Working Group of Pacing, Electrophysiology of the French Society of Cardiology, the Board of the French Society of Cardiology. Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection. Arch Cardiovasc Dis . 2020;
8. Castelletti S, Dagradi F, Goulene K, Danza AI, Baldi E, Stramba-Badiale M, Schwartz PJ. A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome. Int J Cardiol . 2018;266:89–94.
9. Garabelli P, Stavrakis S, Albert M, Koomson E, Parwani P, Chohan J, Smith L, Albert D, Xie R, Xie Q, Reynolds D, Po S. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide. J Cardiovasc Electrophysiol . 2016;27:827–832.
10. Malone D, Gallo T, Beck J, Clark D. Feasibility of measuring QT intervals with a portable device. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm . 2017;74:1850–1851.
11. Cheung CC, Davies B, Gibbs K, Laksman ZW, Krahn AD. Multi-lead QT Screening is Necessary for QT Measurement: Implications for Management of Patients in the COVID-19 Era. JACC Clin Electrophysiol[Internet]. 2020 [cited 2020 Apr 21];Available from: http://electrophysiology.onlinejacc.org/content/early/2020/04/06/j.jacep.2020.04.001
12. Vicente Jose, Johannesen Lars, Mason Jay W., Crumb William J., Pueyo Esther, Stockbridge Norman, Strauss David G. Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil. J Am Heart Assoc . 4:e001615.
13. Haberman ZC, Jahn RT, Bose R, Tun H, Shinbane JS, Doshi RN, Chang PM, Saxon LA. Wireless Smartphone ECG Enables Large-Scale Screening in Diverse Populations. J Cardiovasc Electrophysiol . 2015;26:520–526.
14. Haverkamp HT, Fosse SO, Schuster P. Accuracy and usability of single-lead ECG from smartphones - A clinical study. Indian Pacing Electrophysiol J . 2019;19:145–149.